Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A technological platform to optimize combinatorial treatment design and discovery for chronic spinal cord injury.
Guertin PA. Guertin PA. J Neurosci Res. 2008 Nov 1;86(14):3039-51. doi: 10.1002/jnr.21761. J Neurosci Res. 2008. PMID: 18615646 Review.
Can the spinal cord learn and remember?
Guertin P. Guertin P. ScientificWorldJournal. 2008 Aug 1;8:757-61. doi: 10.1100/tsw.2008.106. ScientificWorldJournal. 2008. PMID: 18677430 Free PMC article. Review.
Tonic and Rhythmic Spinal Activity Underlying Locomotion.
Ivanenko YP, Gurfinkel VS, Selionov VA, Solopova IA, Sylos-Labini F, Guertin PA, Lacquaniti F. Ivanenko YP, et al. Among authors: guertin pa. Curr Pharm Des. 2017 May 12;23(12):1753-1763. doi: 10.2174/1381612823666170125152246. Curr Pharm Des. 2017. PMID: 28128063 Review.
Double-Blind, Placebo-Controlled, Randomized Phase I/IIa Study (Safety and Efficacy) with Buspirone/Levodopa/Carbidopa (SpinalonTM) in Subjects with Complete AIS A or Motor-Complete AIS B Spinal Cord Injury.
Radhakrishna M, Steuer I, Prince F, Roberts M, Mongeon D, Kia M, Dyck S, Matte G, Vaillancourt M, Guertin PA. Radhakrishna M, et al. Among authors: guertin pa. Curr Pharm Des. 2017;23(12):1789-1804. doi: 10.2174/1381612822666161227152200. Curr Pharm Des. 2017. PMID: 28025945 Clinical Trial.
The Utility of Interappendicular Connections in Bipedal Locomotion.
McMillan D, de Leon R, Guertin PA, Dy C. McMillan D, et al. Among authors: guertin pa. Curr Pharm Des. 2017;23(12):1734-1740. doi: 10.2174/1381612822666161216115947. Curr Pharm Des. 2017. PMID: 27981907 Review.
Rationale for Assessing Safety and Efficacy of Drug Candidates Alone and in Combination with Medical Devices: The Case Study of SpinalonTM.
Guertin PA. Guertin PA. Curr Pharm Des. 2017;23(12):1778-1788. doi: 10.2174/1381612822666161208094300. Curr Pharm Des. 2017. PMID: 27928968 Review.
Pharmacological approaches to chronic spinal cord injury.
Steuer I, Rouleau P, Guertin PA. Steuer I, et al. Among authors: guertin pa. Curr Pharm Des. 2013;19(24):4423-36. doi: 10.2174/1381612811319240009. Curr Pharm Des. 2013. PMID: 23360274 Review.
Oral administration of a tri-therapy for central pattern generator activation in paraplegic mice: proof-of-concept of efficacy.
Guertin PA, Ung RV, Rouleau P. Guertin PA, et al. Biotechnol J. 2010 Apr;5(4):421-6. doi: 10.1002/biot.200900278. Biotechnol J. 2010. PMID: 20349462
New pharmacological approaches against chronic bowel and bladder problems in paralytics.
Guertin PA. Guertin PA. World J Crit Care Med. 2016 Feb 4;5(1):1-6. doi: 10.5492/wjccm.v5.i1.1. eCollection 2016 Feb 4. World J Crit Care Med. 2016. PMID: 26855887 Free PMC article.
New avenues for reducing intensive care needs in patients with chronic spinal cord injury.
Guertin PA. Guertin PA. World J Crit Care Med. 2016 Nov 4;5(4):201-203. doi: 10.5492/wjccm.v5.i4.201. eCollection 2016 Nov 4. World J Crit Care Med. 2016. PMID: 27896143 Free PMC article.
65 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback